Published in
American Society of Hematology, Blood Advances, 17(4), p. 4086-4090, 2020
DOI: 10.1182/bloodadvances.2020002060
Links
Tools
Venous thromboembolism associated with CD19-directed CAR T-cell therapy in large B-cell lymphoma
Journal article published in 2020 by
Hamza Hashmi 
,
Abu-Sayeef Mirza,
Alicia Darwin ,
Constantine Logothetis,
Franco Garcia,
Anuhya Kommalapati,
Rahul S. Mhaskar,
Christina Bachmeier ,
Julio C. Chavez,
Bijal Shah,
Javier Pinilla-Ibarz,
Farhad Khimani,
Aleksandr Lazaryan ,
Hien Liu ,
Marco L. Davila
and other authors.
,
Abu-Sayeef Mirza,
Alicia Darwin ,
Constantine Logothetis,
Franco Garcia,
Anuhya Kommalapati,
Rahul S. Mhaskar,
Christina Bachmeier ,
Julio C. Chavez,
Bijal Shah,
Javier Pinilla-Ibarz,
Farhad Khimani,
Aleksandr Lazaryan ,
Hien Liu ,
Marco L. Davila
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 
Abstract
Key Points VTE developed in 11% of lymphoma patients after CAR T-cell therapy and was managed safely with anticoagulation. Coagulation abnormalities after CAR T-cell therapy occur but do not commonly lead to bleeding events.